Skip to main content

Table 1 Summary of immune therapies in clinical use

From: A current perspective on cancer immune therapy: step-by-step approach to constructing the magic bullet

Immune therapy

Target

Stage

Cancer type

Ref.

Ipilimumab

CTLA-4

Clinical use

Advanced melanoma

107

Nivolumab

PD-1

Clinical use

Melanoma

Renal cancer

NSLC

108

109

110

Pembrolizumab

PD-1

Clinical use

Melanoma

111

Atezolizumab

PD-L1

Clinical use

NSLC

Clear renal cancer bladder cancer

112

113

Sipileucel

Peripheral blood mononuclear cells

Clinical use

Prostate cancer

114